Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

Quantity Surveying and Construction Management department aspires to excellence
2017-08-14

Description: Prof Kahilu Kajimo-Shakantu Tags: Prof Kahilu Kajimo-Shakantu 

From the left: Prof Danie Vermeulen, Dean of the
Faculty of Natural and Agricultural Sciences;
Prof Kahilu Kajimo-Shakantu, Head of the Department
of Quantity Surveying and Construction Management;
Prof Francis Petersen, Rector and Vice-Chancellor
at the UFS; and Dr Franco Geminiani, chairing the
panel from the South African Council for the Project
and Construction Management Professions.
Photo: Leonie Bolleurs

Achieving programme accreditation from the respective professional bodies is the ultimate goal for the Department of Quantity Surveying and Construction Management at the University of the Free State (UFS). This is according to Prof Kahilu Kajimo-Shakantu, the head of this department. This hallmark of quality reflects the university’s aspiration towards excellence.

Construction Management programmes reviewed
The university recently received a visit by a panel, representing the South African Council for the Project and Construction Management Professions (SACPCMP) to re-accredit programmes offered by the Department of Quantity Surveying and Construction Management. During the accreditation visit, the panel evaluated the programmes to determine whether they met the minimum requirements according to a set of pre-determined criteria.

When reviewing the programmes: BSc and BSc Hons Construction Management respectively, as well as the Project Management stream of the Masters programme in Land and Property Development Management (MLPM), the panel looked at programme design and outcomes including curriculum, study material and exam papers, institutional support, student recruitment, admission, development, retention and throughput, staffing recruitment and development, teaching and learning strategies, quality assurance, facilities, infrastructure and resources, professional development, industry and practical exposure and postgraduate policies, procedures and regulations, including research activities.

If the minimum requirements are achieved, the Department of Quantity Surveying and Construction Management at the UFS will receive accreditation for its programmes from 1 April 2017 to 31 March 2022.

It will also mean that we are certified
as producing quality employable
graduates who are well prepared to
enter the industry and make a difference.

Currently, the department has full accreditation by the SACPCMP (until March 2017) and the SACQSP (until December 2017).

Later this month, a panel from the South African Council for Property Valuation Profession (SACPVP) will review the accreditation of the Valuation stream of the MLPM programme. The South African Council for Quantity Surveying Profession responsible for accrediting the Quantity Surveying programmes will visit the university in 2018.

Certified as producing quality students

Prof Kajimo-Shakantu said: “If we maintain our accreditation, it will reflect that the UFS is among the best, with programmes which are recognised by professional bodies that set competence standards for professional registration of students. It will also mean that we are certified as producing quality employable graduates who are well prepared to enter the industry and make a difference. The programmes contribute to the development of the much-needed critical skills in the built environment.”


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept